Monday, 24 September 2018

AstraZeneca diabetes drug cuts heart risks in major study

AstraZeneca said on Monday its diabetes drug Farxiga met a key goal in a major clinical study designed to show the heart-protecting benefits of the medicine.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)